Dowling & Yahnke LLC Pfizer Inc Transaction History

Dowling & Yahnke LLC

$215 Million
Q3 2022

A detailed history of Dowling & Yahnke LLC transactions in Pfizer Inc stock. As of the latest transaction made, Dowling & Yahnke LLC holds 204,469 shares of PFE stock, worth $6.06 Million. This represents 4.17% of its overall portfolio holdings.

Number of Shares

204,469

Previous 203,946 0.26%

Holding current value

$6.06 Million

Previous $10.7 Million 16.32%

% of portfolio

4.17%

Previous 0.5%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$43.76 - $53.42 $22,886 - $27,938	523 Added 0.26%	204,469 $8.95 Million
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $69,562 - $82,479	-1,495 Reduced 0.73%	203,946 $10.7 Million
Q1 2022 May 04, 2022	SELL	$45.75 - $56.69 $424,194 - $525,629	-9,272 Reduced 4.32%	205,441 $10.6 Million
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $114,910 - $170,336	-2,781 Reduced 1.28%	214,713 $12.7 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $45,294 - $58,184	1,154 Added 0.53%	217,494 $9.35 Million
Q2 2021 Jul 21, 2021	BUY	$35.91 - $40.68 $94,191 - $106,703	2,623 Added 1.23%	216,340 $8.47 Million
Q1 2021 Apr 29, 2021	SELL	$33.49 - $37.77 $115,440 - $130,193	-3,447 Reduced 1.59%	213,717 $7.74 Million
Q4 2020 Jan 28, 2021	BUY	$33.47 - $42.56 $655,945 - $834,090	19,598 Added 9.92%	217,164 $7.99 Million
Q3 2020 Oct 19, 2020	BUY	$31.75 - $37.25 $136,715 - $160,398	4,306 Added 2.23%	197,566 $7.25 Million
Q2 2020 Jul 31, 2020	BUY	$30.12 - $36.54 $202,797 - $246,023	6,733 Added 3.61%	193,260 $6.32 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $395,719 - $565,396	-14,640 Reduced 7.28%	186,527 $6.09 Million
Q4 2019 Jan 27, 2020	SELL	$32.92 - $37.36 $315,439 - $357,983	-9,582 Reduced 4.55%	201,167 $7.88 Million
Q3 2019 Oct 29, 2019	SELL	$32.49 - $42.13 $2,729 - $3,538	-84 Reduced 0.04%	210,749 $7.57 Million
Q2 2019 Jul 22, 2019	BUY	$36.98 - $41.52 $109,534 - $122,982	2,962 Added 1.42%	210,833 $9.13 Million
Q1 2019 Apr 30, 2019	BUY	$37.5 - $41.2 $261,000 - $286,752	6,960 Added 3.46%	207,871 $8.83 Million
Q4 2018 Jan 24, 2019	BUY	$38.47 - $43.86 $124,488 - $141,930	3,236 Added 1.64%	200,911 $9.29 Million
Q3 2018 Oct 30, 2018	SELL	$34.47 - $41.81 $108,373 - $131,450	-3,144 Reduced 1.57%	197,675 $8.71 Million
Q2 2018 Jul 30, 2018	SELL	$32.98 - $35.16 $81,658 - $87,056	-2,476 Reduced 1.22%	200,819 $7.29 Million
Q1 2018 May 01, 2018	SELL	$31.91 - $37.02 $106,994 - $124,128	-3,353 Reduced 1.62%	203,295 $7.22 Million
Q4 2017 Feb 02, 2018	SELL	$33.26 - $35.29 $32,162 - $34,125	-967 Reduced 0.47%	206,648 $7.49 Million
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $6.44 Million - $7.09 Million	207,615	207,615 $7.41 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dowling & Yahnke LLC with notifications on news.

Account

Dowling & Yahnke LLC Pfizer Inc Transaction History